Private Market View

Genesis Therapeutics

Drug Discovery · Burlingame, CA · Founded 2019 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
$327.4M
Last round
Early Stage VC (Series B)
Aug 2023
Cap table — not yet on record

Genesis Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
  • ·Post-money valuations for all 3 rounds
  • ·The complete investor list — 22 names
  • ·Watchlist + deal alerts for Genesis Therapeutics
Create free account
No card required

Frequently asked

Where does Genesis Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Genesis Therapeutics's 3 recorded funding rounds.